National Genetics Institute

National Genetics Institute (NGI), a subsidiary of LabCorp, is a premier specialty laboratory focused on high-sensitivity molecular testing for infectious diseases and genetics. Founded in 1991 and acquired by LabCorp in 2000, NGI is a pioneer in nucleic acid testing (NAT) for blood screening and clinical trial support. The company provides ultra-sensitive assays for the detection and quantification of viral targets, including Hepatitis C (HCV), HIV, and Hepatitis B (HBV). NGI serves a diverse global clientele, including major pharmaceutical companies, biotechnology firms, and blood donor organizations. Its expertise in virology and molecular diagnostics makes it a critical partner in drug development, biomarker validation, and disease management.